Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Med. 1999 Dec;5(12):1359-64.

Clinical applications of angiogenic growth factors and their inhibitors.

Author information

  • 1Department of Molecular Oncology Genentech DNA Way South San Francisco, California 94080, USA. nf@gene.com

Abstract

Promoting the formation of new collateral vessels in ischemic tissues using angiogenic growth factors (therapeutic angiogenesis) is a an exciting frontier of cardiovascular medicine. Conversely, inhibition of the action of key regulators of angiogenesis, such as VEGF, constitutes a promising approach for the treatment of solid tumors and intraocular neovascular syndromes. These concepts are being tested now in clinical trials.

PMID:
10581076
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk